The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine
Open Access
- 2 February 2021
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 19 (1) , 1-10
Abstract
Background: Chronic kidney disease is considered as a global health problem. Hemodialysis (HD), following renal transplantation, is the most common form of renal replacement therapy. However, HD may impact the quality of life (QOL). Pain is a frequent complaint among this population that also affects their QOL. The purposes of this study were to assess pain and QOL among end-stage renal disease (ESRD) patients on HD and to examine their association. Methods: This was a multicenter, cross-sectional study that occurred in Palestine between August and November 2018. Brief Pain Inventory and European Quality of Life scale 5 dimensions (EQ-5D) scale, including its European Quality of Life visual analogue scale (EQ-VAS) component, were used to assess pain and QOL, respectively. Results: A total of 300 participants were included in the final study. The average age of the subjects was 54 ± 16 years. Their median EQ-5D score was 0.68 [0.54–0.88], whereas their median EQ-VAS score was 60 [40–75]. A statistically significant association of pain severity score with EQ-5D score was found (r = − 0.783, p < 0.001). The association between pain interference score and EQ-5D score was also found to be statistically significant (r = − 0.868, p < 0.001). Similarly, pain severity score was significantly assocsiated with EQ-VAS score (r = − 0.590, p < 0.001), the same as was the pain interference score (r = − 0.647, p < 0.001). Moreover, age, gender, BMI, employment, educational level, income level, dialysis vintage, previous kidney transplantation, and chronic medication use were all significantly correlated with QOL. Regression analysis showed that patients aged < 60 years (p < 0.001), those with lower pain severity scores (p = 0.003), and those with lower pain interference scores (p < 0.001) had significantly higher QOL scores. Conclusions: Pain has a significant negative impact on QOL in ESRD patients undergoing HD. The subgroups that were at higher risk included elderly patients, females, those with higher BMI, those without a formal education, those unemployed, those living with low monthly income, smokers, those who have multiple comorbidities, and patients with longer dialysis vintage. Our findings provide reliable data for educators and clinicians working with HD patients.Keywords
This publication has 68 references indexed in Scilit:
- Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up studyBMJ Open, 2013
- Spiritual coping, religiosity and quality of life: A study on Muslim patients undergoing haemodialysisNephrology, 2013
- Quality of life in dialysis patients from the United Arab EmiratesJournal of Family and Community Medicine, 2013
- Health Related Quality of Life in Patients with Type 2 Diabetes Mellitus in Iran: A National SurveyPLOS ONE, 2012
- Lifestyle physical activity among urban Palestinians and Israelis: a cross-sectional comparison in the Palestinian-Israeli Jerusalem risk factor studyBMC Public Health, 2012
- Psychometric Evaluation of the Arabic Brief Pain Inventory in a Sample of Lebanese Cancer PatientsJournal of Pain and Symptom Management, 2011
- Dose-dependent positive association between cigarette smoking, abdominal obesity and body fat: cross-sectional data from a population-based surveyBMC Public Health, 2011
- Impact of Pain and Symptom Burden on the Health-Related Quality of Life of Hemodialysis PatientsJournal of Pain and Symptom Management, 2010
- Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatmentBMC Nephrology, 2008
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001